Osmotica Study Site-138 is a clinical research site located in Cullman, Alabama, United States 35058.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Osmotica Study Site-138 has participated in 1 clinical trials.
Therapeutic areas: Spasticity, Multiple Sclerosis.
Sponsors: RVL Pharmaceuticals, Inc..
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Osmotica Study Site-138 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Osmotica Study Site-138 has 1 clinical trials on record. Their work covers Spasticity, Multiple Sclerosis.
Osmotica Study Site-138 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.